Value of Syntara, page-153

Hi borrks

I'll try to frame my observations as best I can , in short..

ASX Announcements are not Marketing , ASX Announcements are not Public Relations, ASX Announcements are not Promotion , they are the very bare Regulatory Requirement for a Publicly Listed Entity registered on the ASX..

A decent Company "Well Balanced " understands how critical it is to deliver Positive Phase II Data to Market as this not only demonstrates "Solid Science resulting from a well disciplined CSO and Science Team" but also managements ability to impart Value, in this case Market Value of SNT 5505 and also immediately Share Holder Value as a fk load of risk was removed and the Treatment SNT 5505 is far closer to commercialisation..

Gary shows little concern for retail investors and is content with the Instos and funds ,, but as Platinum has shown even the Funds and Instos have demands on invested funds... put it like this if SNT had run to 9c /10c which would have been an easy push as in February the SP kissed 9.5c..

So Today with Positive Phase II Data the company is only valued @5.9c ?????????????? so prior to risk removal of not hitting the Phase II Primary End Point the company was valued by the market at circa 70% more than after Positive Phase II?????????????????

If SNT Management don't place a high value on gaining SH value ..who will???? certainly not our competitors who are all vying for our investment capital..

Friday and today are very disappointing from the perspective of an investor but I'm hoping Gary receives enough pressure to apply effort to awareness ,,that's Investor Awareness not just the Scientific Community,,, it's all about Balance and SNT certainly dont currently understand balance or ensuring SH value from Positive Scientific Data ..

in context SNT 5505 has been under development for over 3.5 years with an investment of $20m plus a year and positive results devalued the company more than $10m ?? NZT